l General Information |
Product Name | Epalrestat |
General description | Epalrestat is an aldose reductase inhibitor. |
Synonym | (5Z)-5-[(2E)-2-Methyl-3-phenyl-2-propen-1-ylidene]-4-oxo-2-thioxo-3-thiazolidineacetic acid; Epalrestatum; ONO-2235 |
Purity | ≥96.0%(HPLC) | CAS Number | 82159-09-9 |
Formula | C15H13NO3S2 | Molecular Weight | 319.393 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Red or dark red solid |
Solubility(25℃) | DMSO | Slightly soluble |
Ethanol | Very slightly soluble |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | Epalrestat is an aldose reductase inhibitor. |
Application | Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. |
l Packaging & Storage |
Packaging | 250mg; 1g |
Storage temp. | 0-5℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
